Inogen (INGN) Non Operating Income (2013 - 2026)
Inogen's (INGN) quarterly Non Operating Income came in at $838000.0 in Q1 2026, down 39.49% year-on-year from $1.4 million in Q1 2025, and down 56.87% on a QoQ basis from $1.9 million in Q4 2025.
Inogen (INGN) Non Operating Income (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Non Operating Income data on file, last reported at $838000.0 in Q1 2026.
- On a quarterly basis, Non Operating Income fell 39.49% year-over-year to $838000.0 in Q1 2026; TTM through Mar 2026 was $6.3 million, a 6.84% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, up 13.05% from the prior year.
- Non Operating Income for Q1 2026 stood at $838000.0, down from $1.9 million in the prior quarter.
- Over the last five years, Non Operating Income for INGN reached as high as $2.0 million in Q4 2022 and fell as low as -$497000.0 in Q2 2022.
- Historically, Non Operating Income has averaged $1.3 million across 5 years, with a median of $1.5 million in 2024.
- On a YoY basis, Non Operating Income climbed as much as 1035.19% in 2022 and fell as far as 249.25% in 2022.
- Year by year, Non Operating Income stood at $2.0 million in 2022, then dropped by 6.24% to $1.9 million in 2023, then plunged by 31.41% to $1.3 million in 2024, then soared by 49.58% to $1.9 million in 2025, then sank by 56.87% to $838000.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $838000.0 in Q1 2026, $1.9 million in Q4 2025, and $1.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -18.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | 838,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 838,000.00 |
| Dec 31, 2025 | 1.94 Mn |
| Sep 30, 2025 | 1.68 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.39 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 1.89 Mn |
| Sep 30, 2023 | 1.40 Mn |
| Jun 30, 2023 | 1.98 Mn |
| Mar 31, 2023 | 1.76 Mn |
| Dec 31, 2022 | 2.02 Mn |
| Sep 30, 2022 | 856,000.00 |
| Jun 30, 2022 | -497,000.00 |
| Mar 31, 2022 | -404,000.00 |
| Dec 31, 2021 | -216,000.00 |
| Sep 30, 2021 | -445,000.00 |
| Jun 30, 2021 | 333,000.00 |